Bausch + Lomb Corporation (NYSE/TSX ... for the visual correction of aphakia following removal of a cataractous lens. The enVista Aspire toric IOL is indicated for primary implantation in the ...
Bausch + Lomb announced the commercial launch of its enVista Aspire monofocal and toric intraocular lenses (IOLs) in the ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health ... adult patients for the visual correction of aphakia following removal of a cataractous lens. The enVista Aspire toric IOL is ...
Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results